Your new post is loading...
The presentation summarizes the global efforts of W.H.O. to support the development, test, and manufacture of COVID-19 vaccine in record times. The time for approval of a vaccine averages 10 years. However, the process is expected to be reduced by more than 5 times for COVID-19. This presentation, updated as of October 6, 2020, summarizes the W.H.O. global efforts towards this goal, and also provides and excellent summary of the vaccine development process.
As of today, at least 213 COVID-19 vaccines are under development, including 178 preclinical candidates and 35 vaccines in human trials. Nine vaccines have already entered advanced Phase III trials. With typical approval rates of 7% for preclinical candidates, and 20% for those entering human trials, more than 30 vaccines against SARS-CoV-2 could be approved in the following years, and about two of them in the following months.
